Abstract
The incidence of synchronous or metachronous bilateral breast cancer (SBBC vs. MBBC) has been reported to range from 1.4 to 11.8%. BRCA1/2 deleterious......
小提示:本篇文献需要登录阅读全文,点击跳转登录